Black walnut hulls (Juglans nigra L.), Juglandaceae
Australian Herbal Pharmacopoeia (working title) · Monograph AIP-PH-JUGNIG · Version 1.0 draft
Date: 2026
Status: working document, version 1.0. Not a statutory standard.
Prepared by: the Australian Institute of Pharmacognosy, Far North Queensland, Australia. Every author and contributor is named at the end of the monograph.

0. Free-teaser block
0.1 Identity card
| Register number | AIP-PH-JUGNIG (MediHerb A–Z list No. 18) |
| Title | Black walnut hulls (Juglans nigra L.), Juglandis nigrae pericarpium |
| Version / year | 1.0 draft, 2026. Next review 2029, or sooner if a human study of the hull reports or AIP bench data become available |
| Accepted binomial | Juglans nigra L., Species Plantarum: 997 (1753). Accepted in the World Checklist of Vascular Plants (WCVP), version 16.0 of 04/06/2026, the dataset shown by Plants of the World Online, read through ChecklistBank in September 2026; IPNI 279034-2 [1] |
| Family | Juglandaceae, order Fagales (APG IV, as followed by WCVP) [1,46,47] |
| Plant part | The fruit hull: the fleshy outer layers of the fruit (exocarp and mesocarp) that enclose the hard nut, used fresh-green or dried. Sold in Australia as "hulls" or "green hulls" [5,9,10,14] |
| Latin drug name | Juglandis nigrae pericarpium (AIP form). No pharmacopoeia has set a Latin name for this drug; the European walnut hull was called Cortex fructus juglandis in older European pharmacy [12] |
| Principal synonyms | Wallia nigra (L.) Alef. (homotypic); Juglans pitteursii C.Morren, J. rugosa Dode, J. nigra [unranked] oblonga Marshall, J. nigra f. laciniata Rehder, J. nigra f. oblonga (Marshall) Fernald (heterotypic) [1] |
| Common names | English: black walnut, eastern black walnut, American walnut [3,20]. French: noyer noir, noyer noir d’Amérique [17]. German: Schwarznuss [17] |
| Pharmacopoeial status elsewhere | Ph. Eur.: no monograph for any J. nigra drug in the edition held (8.0) [32]. EMA/HMPC: a monograph exists for the leaf of a different species, Juglans regia (Juglandis folium, cutaneous use), and none for J. nigra [24]. USP–NF, BP, WHO, ChP, API: no monograph found in the sources read. The US Dispensatory of 1918 carries butternut (J. cinerea) bark, with the other walnuts as notes [13]. The British Herbal Pharmacopoeia was not among the sources read for this edition (section 18) |
| Australian status | Permissible Ingredients Determination: yes, item 2846 JUGLANS NIGRA, purposes A (active), E (excipient) and H (homoeopathic), no specific requirements [7]. ARTG: at least 25 listed medicines contain J. nigra, among them a single-herb hull capsule and MediHerb Wormwood Complex [9,10]. Poisons Standard: not named, and juglone is not scheduled [6]. Queensland: the fresh fruit is a listed Mediterranean fruit fly carrier; dried hulls count as processed and fall outside that rule [4]. Not native; no Australian record in Queensland [2] |
| Named markers | Hydrojuglone glucoside (CID 477404): identity, proposed; limit to be set. Juglone (CID 3806): safety marker, proposed upper limit not yet set. Ellagic acid (CID 5281855), total after hydrolysis: assay, proposed; no limit. No pharmacopoeial limit exists for any of them (sections 7, 18) |
| Evidence snapshot | Threadworm and other intestinal worms: Tier T, 0 trials. Protozoal gut infection: Tier T, 0 trials. Fungal skin infection (topical): Tier T, 0 trials (laboratory work exists only for European walnut leaf). Laxative: Tier T, 0 trials. Antibacterial, antiprotozoal and antiproliferative effects: Tier P, laboratory studies only [5,9,18,20,24,28,30] |
| Suggested citation | Ridley T, Iggulden L. Black walnut hulls (Juglans nigra L.), Juglandis nigrae pericarpium. AIP-PH-JUGNIG, version 1.0 draft. Cardwell: Australian Institute of Pharmacognosy; 2026. DOI to be assigned |
| Provenance | Original AIP data: none. Every analytical figure, limit, method and dose belongs to the source cited beside it. Sections 4, 5, 7, 8, 9 and 10 carry AIP bench data pending (no AIP voucher, section, plate or run yet). The map (Figure 9), charts (Figures 10–13) and drawings (Figures 3d, 5, 6) are AIP drawings from cited data |
| Compiler and review | Compiled by Dr Thomas Ridley (Education and Research). Technical review: Dr Fiona MacAllister (Botanical, sections 1-5, 10), reviewed in 2026; Dr Hana Suzuki (QA, sections 6-10), reviewed in 2026; Dr Eleanor Whitcombe (Medicine, sections 12, 13, 15), reviewed in 2026; Dr Thomas Ridley (Education and Research, evidence and citation audit of all sections and figures), reviewed in 2026; Jesse Kirby (Community Outreach, figures, captions, credit lines and whole-document layout), reviewed in 2026. Published: not yet. Last modified: 2026. Version 1.0 draft |
| Canonical URL | /pharmacopoeia/juglans-nigra/ (on publication) |

0.2 Summary
Black walnut hull is the fleshy outer coat of the fruit of Juglans nigra, a large timber and nut tree of the eastern and central United States and southern Ontario. The hull is green and firm when the fruit falls in autumn. It turns black and soft within weeks and stains skin a lasting brown-black. Herbal practice uses the hull, green or dried, and discards the hard nut inside. The tree is grown in Europe and in a few gardens in south-eastern Australia. No Queensland record exists, and Australian supply is imported.
No pharmacopoeia carries this drug, so there is no official definition, no identity test and no limit. The chemistry is well described in the last few years. Vouchered pericarp from Hungary yielded 161 tentatively identified phenolic compounds. Gallotannins and ellagitannins dominate the pericarp, and the naphthalene compounds typical of walnuts are present as well. The most abundant of these is hydrojuglone glucoside, the stored precursor of juglone. Juglone itself forms when the tissue is bruised, cut or extracted. Free juglone in intact hull is close to zero.
Australian practitioners prescribe a 1:10 liquid extract at 10 to 40 mL a week as an anthelmintic. That use comes from nineteenth-century American practice, and older European use of the European walnut’s hull. No clinical trial of the hull was found. The laboratory evidence is antibacterial, antiprotozoal and antiproliferative work on extracts and pure compounds. The safety questions are juglone, pregnancy, tree-nut allergy, mould, and toxicity to horses from black walnut wood.

0.3 Contents with extent
| Section | Extent (A4 pages, estimated for this printing) |
|---|---|
| 0 Free-teaser block | 6 |
| 1 Nomenclature | 2 |
| 2 Definition | 1 |
| 3 Source and Australian supply, with 3.1 origin, climate and chemistry | 4 |
| 4 Macroscopy | 4 |
| 5 Microscopy | 2 |
| 6 Chemistry | 2 |
| 7 Named markers and assay limits | 2 |
| 8 TLC fingerprint | 1 |
| 9 HPLC fingerprint | 2 |
| 10 Identity, purity, adulterants and contaminants | 2 |
| 11 Traditional use | 2 |
| 12 Current practice | 1 |
| 13 Clinical evidence | 2 |
| 14 Pharmacology | 2 |
| 15 Safety | 3 |
| 16–18 Discussion, conclusions, research needed | 4 |
| 19 References | 2 |
| 20 Document control | 3 |
| Totals (draft) | 47 A4 pages in this printing. 37 embedded figures: 13 licensed or public-domain photographs of the living tree, leaves, flowers and fruit; 4 licensed photographs of the crude drug and the nut; 5 public-domain plates, drawings and paintings; 2 licensed micrographs and fruit sections of the European walnut (J. regia, labelled so); 1 licensed HPTLC plate (other plants, including walnut leaf of J. regia); 1 licensed UHPLC chromatogram of black walnut pericarp; 2 licensed chemistry figures; 1 licensed photograph of hull staining; 1 AIP composite of PubChem structures; 7 AIP drawings, maps and charts. About 22 tables. 0 AIP photomicrographs, 0 AIP chromatograms, 0 AIP plates. 0 clinical trials of the hull to grade; ClinicalTrials.gov and the WHO trials portal searched, ANZCTR direct search still to be done by hand; 2 literature databases searched; ARTG, the TGA adverse event database and the TGA website checked. 52 numbered references |
Gaps stated plainly. AIP holds no voucher, photomicrograph, TLC plate or chromatogram of black walnut hull. No published microscopical description of the hull was found. Figure 4 therefore shows licensed sections of the European walnut’s husk, and Figure 5 is an AIP schematic from descriptions of related species. No published TLC fingerprint of the hull was found; Figure 7 shows a published HPTLC plate that includes walnut leaf of J. regia, labelled so. The photographs of the crude drug carry no scale bar. About twenty older papers on hull toxicity in horses and dogs, skin reactions, hull pharmacology and fungicide residues are being obtained in full text; none is used here. The CITES checklist, DAFF BICON import conditions, the ANZCTR site and the TGA recalls database could not be read or fully queried by our tools in September 2026 and are to be checked by hand.
0.4 Contributors and access
Compiled by Dr Thomas Ridley, Head of Education and Research: literature and register searches, source reading, all sections, AIP drawings and charts, and the evidence record behind this monograph. Technical review has been requested from Botanical (Dr Fiona MacAllister, sections 1–5 and 10), QA (Dr Hana Suzuki, sections 6–10) and Medicine (Dr Eleanor Whitcombe, sections 12, 13 and 15). The Botanical, QA and Medicine reviews are on record, and each reviewer is credited once their review is. Education and Research then audited every reference, identifier and figure licence against its source; because the same department compiled the monograph, the Librarian’s reference audit is still to come. Dr Luke Iggulden, Chief Scientific Officer, is senior author: he set the scope of the pharmacopoeia series and made the research possible. A preview of the monograph and all of section 15 (Safety) are free to every reader; the full text is for Scholar members and above, or the AUD $20 copy of this one title.
Free to every reader. The safety section of every monograph is open to everyone, signed in or not. In an emergency call 000. For poisoning, call the Poisons Information Centre on 13 11 26.
15. Safety
Red flags first.
- Pregnancy and breastfeeding: avoid. This is the Medicine position for this monograph. No human data exist for the hull in pregnancy or lactation; the evidence-based text on herbal medicines in pregnancy and lactation by Mills and colleagues has no entry for black walnut or Juglans [51]. Bascom lists black walnut among herbs that should not be taken in pregnancy [16]. The ARTG listing of MediHerb Wormwood Complex carries "Do not use if pregnant or likely to become pregnant" and "Do not use while breastfeeding" [9], but that product also contains wormwood, so the warning cannot be pinned on the hull. The single-herb hull capsule on the ARTG must carry a statement that pregnant or breastfeeding women seek professional advice before use [10]. MediHerb gives "professional supervision" for pregnancy and lactation, the entry it gives most herbs in its table, and no specific warning (pp. 30, 116) [5]. For the related walnut leaf, the HMPC does not recommend use in pregnancy and lactation for lack of data [24,48]. Juglone is cytotoxic, weakly genotoxic and a skin tumour promoter in animals (below), and the juglone content of a hull dose is unknown. Grade: precautionary; no human data.
- Liver. The TGA adverse event database holds two liver reports with products that contain black walnut: fulminant hepatitis with jaundice, ascites and fatty liver in 2005, with a 29-ingredient "cleanse" product as the sole suspected medicine, and liver injury in 2025, with an antiparasitic combination suspected together with paromomycin [49]. Both products held many other herbs, and the database records suspicion, not cause. No liver injury has been tied to the hull itself. Anyone who develops jaundice, dark urine, pale stools or pain under the right ribs while taking a hull product should stop it and needs prompt assessment. Grade: spontaneous reports, causality not established.
- Tree-nut allergy. The ARTG listing of a hull product carries "Contains tree nuts" [9], and the HMPC notes that allergic reactions should be considered in people allergic to the walnut family [24]. One Australian report describes itching of the lips and mouth, hives and facial swelling after an antiparasitic combination containing black walnut, taken with an oregano oil product; both were suspected [49]. Whether the hull carries the kernel allergens has not been measured. A person allergic to walnuts should avoid the hull. Grade: regulatory warning and one spontaneous report.
- Horses. Black walnut heartwood and wood shavings cause laminitis in horses, and an aqueous heartwood extract given by mouth is the standard experimental model of the disease [24,25]. Juglone itself inhibited equine neutrophil degranulation and oxygen radical release in vitro, and the authors concluded that juglone is not the trigger, at least through neutrophil activation [25]. The hull has not been implicated in the sources read. Hull residues and wood should still be kept away from horses. A case series of dogs that ate black walnut wood, nuts and hulls is being obtained in full text and is not used here.
- Children. No paediatric data and no sourced dose. For the related walnut leaf, even as a cutaneous preparation, the HMPC does not recommend use under 18 years [48]. Stearns gave doses to children in 1801 [11]; that is history, not guidance. Medicine position: not for children while there are no data. Grade: precautionary.
Adverse effects in people. No trial exists, so there are no trial-based adverse-effect data. Duke records "no side effects reported" from one source and the advice to limit use to a few weeks; he also gives "Class 2d", notes that juglone is mutagenic and, citing a secondary source, external carcinogenic effects after chronic use of J. regia (p. 101) [15]. Case reports of skin reactions and staining from black walnut hull juice are being obtained in full text. Hull juice stains skin brown-black; the stain resists washing and fades only as the skin renews (Figure 15b, J. regia) [38]. The Nature’s Sunshine listing carries the stimulant-laxative statement "Prolonged use may cause serious bowel problems" and "Do not use when abdominal pain, nausea or vomiting are present or if you develop diarrhoea" [10]. Those statements come with the laxative indication on the ARTG; whether the hull acts as a stimulant laxative has not been shown.
TGA adverse event reports (DAEN – medicines) [49]. Searched in September 2026 for "juglans", data to September 2026. Eight products containing J. nigra appear, every one a multi-ingredient product; no single-herb hull product has a report. A ninth hit, containing butternut (J. cinerea), was excluded.
| Item | Result |
|---|---|
| Reports (cases), 2003–2025 | 15; 12 with a single suspected medicine; no deaths |
| Products | "Cleanse" and "detox" kits of 29 ingredients, among them the stimulant-laxative herbs cascara and rhubarb (9 reports, 2003–2005 and 2025); antiparasitic combinations (5, 2025); a magnesium-based flush taken with four other suspected products (1, 2021) |
| Gastrointestinal | Diarrhoea 4, vomiting 3, abdominal pain 3, nausea 2, colitis 1, mouth discomfort and salivation 1 |
| Nervous system | Seizure 2 (2003 and 2004, both with cleanse kits of the same range), lethargy 2, headache 1 |
| Liver | Fulminant hepatitis 1 (2005); liver injury 1 (2025, paromomycin co-suspected) |
| Skin and allergy | Rash or itchy rash 2, hives 2, facial swelling 1, oral itching 1 |
| Causality | The database lists suspected reactions; inclusion does not mean a reaction was confirmed or caused by the medicine [49]. Every product had other active ingredients. None of these reactions can be attributed to the hull on this evidence |
TGA safety alerts, recalls and cancellations [50]. The TGA website was searched in September 2026 for "juglans", "black walnut", "juglone" and "walnut hull". No safety alert, advisory or recall names black walnut or juglone. One product, Hulda Herbs Fresh Green Hulls of Black Walnut Tincture (ARTG 56461), was cancelled at the sponsor’s request under section 30(1)(c) of the Therapeutic Goods Act 1989, effective 30/07/2021; the notice gives no safety reason. The TGA Database of Recalls, Product Alerts and Product Corrections was searched in October 2026 for "juglans", "black walnut", "walnut" and "juglone", for ARTG 91797 and 57518, and for the products named in the adverse event reports: no recall, product alert or product correction was found. That database searches product names and ARTG numbers, not ingredients, so a multi-herb product that contains the hull under another name would not show up through those terms [50].
Toxicology of juglone (HMPC review) [24].
| Finding | Detail |
|---|---|
| Acute oral toxicity | LD50 112 mg/kg in rats and 2.5 mg/kg in mice (Aithal et al. 2011, as cited, p. 20) |
| Repeated dosing | Kidney changes in mice after 7 days at 1 mg/kg; juglone adducts accumulate in kidney (p. 20) |
| Genotoxicity | Ames test positive in TA2637 with S9, negative in TA98 and TA100; positive in the Drosophila SMART assay; judged "scarce and weak" by the HMPC (p. 22) |
| Tumour promotion | Topical juglone promoted papillomas in mouse skin and increased epidermal ornithine decarboxylase (Monks et al. 1990, as cited, p. 21) |
| Ecotoxicity | Toxic to fish below 0.1 mg/L (p. 20) |
| HMPC conclusion (walnut leaf) | Juglone is unstable and present only in traces in dried leaves; genotoxicity not conclusively evaluated and may be limited |
These data come from pure juglone and from the leaf of J. regia. The HMPC’s comfort about dried leaf does not transfer automatically to a 60% ethanol extract of green hull, which is made to capture the naphthalene fraction before it oxidises (section 3.1). That gap is the main safety question for this drug.
Contraindications and cautions, each with its source and grade.
| Statement | Source | Grade |
|---|---|---|
| Pregnancy: avoid | Bascom [16]; no entry in Mills et al. [51]; ARTG warning on a combination [9]; ARTG statement on the single-herb capsule [10]; HMPC for walnut leaf [48]; MediHerb default supervision [5] | Precautionary; no human data |
| Breastfeeding: avoid | ARTG warning on a combination [9]; ARTG statement on the single-herb capsule [10]; HMPC for walnut leaf [48]; MediHerb default supervision [5] | Precautionary; no human data |
| Walnut or tree-nut allergy: avoid | ARTG warning [9]; HMPC [24]; one DAEN report [49] | Regulatory warning; one spontaneous report |
| Serious worm infestation causing blockage | Hechtman, for anthelmintics as a class (p. 106) [14] | Class caution from a practitioner text |
| Abdominal pain, nausea, vomiting or diarrhoea: do not use | ARTG statement on the single-herb capsule [10] | Regulatory statement |
| Children | HMPC for walnut leaf [48]; no paediatric data | Precautionary |
| Stop 7 days before general anaesthesia | MediHerb (p. 30) [5]. The guide gives this for nearly every liquid it lists, so it is a general precaution, with no hull-specific basis | Precautionary |
| Course no longer than a few weeks | Duke, citing a secondary source [15]; Hechtman, short to medium term [14] | Practitioner advice |
Herb–drug interactions. None documented for the hull in the sources read, and no interaction report was found in the TGA database [49]. MediHerb refers users to its own interaction chart, which is not held [5]. For the tannin-rich walnut leaf, the HMPC cites reports that walnut tannins may make alkaloids insoluble, reduce the absorption of other drugs and interfere with iron absorption (p. 25) [24]. Grade: theoretical, carried over from the leaf, with no hull-specific or clinical data. AIP comment (Medicine): taking the hull two hours apart from iron and from other oral medicines is a sensible precaution; it has not been tested.
Microbial and mould risk. A retail hull capsule grew fungi including Aspergillus sp. on culture [27], and fallen fruit lies on damp ground before hulling (section 3.1). Batch testing for moulds and aflatoxins is the practical control (section 10).
Older people. No data.
Overdose. No human case found. The HMPC reports none for walnut leaf [24].
Referral. Anyone considering black walnut hull, and especially anyone pregnant, breastfeeding, allergic to tree nuts or treating a child, should consult a degree-qualified herbalist with competencies and adequate training in pharmacognosy. Suspected worm infestation that persists, any blockage, severe abdominal pain or bleeding, and any sign of liver trouble need prompt assessment.


31 more pages follow · 15,423 words, 32 figures, 20 tables
Still to come in this monograph
- 1. Nomenclature
- 2. Definition
- 3. Source and Australian supply
- 4. Macroscopy
- 5. Microscopy
- 6. Chemistry
- 7. Named markers and assay limits
- 8. TLC fingerprint
- 9. HPLC fingerprint
- 10. Identity, purity, adulterants and contaminants
- 11. Traditional use
- 12. Current practice: use, preparations and doses
- 13. Clinical evidence
- 14. Pharmacology
- 16. Discussion
- 17. Conclusions
- 18. Research still needed
- 19. References
- 20. Document control
The rest of this monograph is open to members. One membership covers every members’ feature on the site.
Checking your membership…
Report an error or submit evidence
If something in this monograph is wrong, out of date or missing, tell us and show us the evidence. Every report is logged under the AIP Evidence Charter and assessed on the evidence alone; the outcome is kept on the record, and an upheld report is corrected with a dated notice on this page.
Open the report form
The Institute sets and publishes its own monographs. The catalogue is in Publications.
